A splicing enhancer in the 3'-terminal c-H-ras exon influences mrna abundance and transforming activity

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6416-6426

  Hwang, Dong Youn ^a   Cohen, Justus B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; ENHANCER REGION; GENE CONTROL; HUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; RNA SPLICING;

EID: 0030858618     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6416-6426.1997     Document Type: Article

References (88)

1. Alwine, J, C. 1985. Transient gene expression control:effects of transfected DNA stability and trans-activation by viral early proteins. Mol. Cell. Biol. 5:1034-1042.
2. Berget, S. M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411-2414.
3. Black, D. L. 1995. Finding splice sites within a wilderness of RNA. RNA 1:763-771.
4. Bollag, G., and F. McCormick. 1991. Regulators and effectors of ras proteins. Annu. Rev. Cell Biol. 7:601-632.
5. Capon, D. J., E. Y. Chen, A. D. Levinson, P. H. Seeburg, and D. V. Goeddel. 1983. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302:33-37.
6. Chang, E. H., M. E. Furth, E. M. Scolnick, and D. R. Lowy. 1982. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297:479-483.
7. Cichutek, K., and P. H. Duesberg. 1986. Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5′ exon (exon -1). Proc. Natl. Acad. Sci. USA 83:2340-2344.
8. Cohen, J. B., S. D. Broz, and A. D. Levinson. 1989. Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell 58:461-472.
9. Cohen, J. B., S. D. Broz, and A. D. Levinson. 1993. U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing. Mol. Cell. Biol. 13: 2666-2676.
10. Cohen, J. B., and A. D. Levinson. 1988. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 334:119-124.
11. Cohen, J. B., J. E. Snow, S. D. Spencer, and A. D. Levinson. 1994. Suppression of mammalian 5′ splice-site defects by U1 small nuclear RNAs from a distance. Proc. Natl. Acad. Sci. USA 91:10470-10474.
12. Damante, G., S. Filetti, and B. Rapoport. 1987. Nucleotide sequence and characterization of the 5′ flanking region of the rat Ha-ras protooncogene. Proc. Natl. Acad. Sci. USA 84:774-778.
13. Dirksen, W. P., R. K. Hampson, Q. Sun, and F. M. Rottman. 1994. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J. Biol. Chem. 269:6431-6436.
14. Dirksen, W. P., Q. Sun, and F. M. Rotman. 1995. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J. Biol. Chem. 270:5346-5352.
15. Dominski, Z., and R. Kole. 1991. Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol. 11:6075-6083.
16. Dominski, Z., and R. Kole. 1992. Cooperation of pre-mRNA sequence elements in splice site selection. Mol. Cell. Biol. 12:2108-2114.
17. Dominski, Z., and R. Kole. 1994. Identification of exon sequences involved in splice site selection. J. Biol. Chem. 269:23590-23596.
18. Ebert, R., R. W. Wiseman, J. C. Barrett, E. Reiss, G. Rollich, and D. Schiffmann. 1992. Characterization of the Syrian hamster c-Ha-ras gene and intron-D-exon transcript. Mol. Carcinog. 5:254-258.
19. Fasano, O., E. Taparowsky, J. Fiddes, M. Wigler, and M. Goldfarb. 1983. Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J. Mol. Appl. Genet. 2:173-180.
20. Firulli, B. A., G. R. Anderson, D. L. Stoler, and S. D. Estes. 1993. Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses. J. Virol. 67: 6857-6862.
21. Fredrickson, T. N., R. R. O'Neill, R. A. Rutledge, T. S. Theodore, M. A. Martin, S. K. Ruscettl, J. B, Austin, and J. W. Hartley. 1987. Biologic and molecular characterization of two newly isolated ras-containing murine leukemia viruses. J. Virol. 61:2109-2119.
22. Fu, X. Y., H. Ge, and J. L. Manley. 1988. The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3′ splice site in alternative splicing. EMBO J. 7:809-817.
23. Gontarek, R. R., and D. Derse. 1996. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16:2325-2331.
24. Green, M. R. 1991. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell. Biol. 7:559-599.
25. Gunderson, S. I., K. Beyer, G. Martin, W. Keller, W. C. Boelens, and L. W. Mattaj. 1994. The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell 76:531-541.
26. Hampson, R. K., L. La Follette, and F. M. Rottman. 1989. Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences. Mol. Cell. Biol. 9:1604-1610.
27. Honkawa, H., W. Masahashi, S. Hashimoto, and T. Hashimoto-Gotoh. 1987. Identification of the principal promoter sequence of the c-H-ras transforming oncogene:deletion analysis of the 5′ -flunking region by focus formation assay. Mol. Cell. Biol. 7:2933-2940.
28. Hoshijima, K., K. Inoue, I, Higuchi, H. Sakamoto, and Y. Shimura. 1991. Control of doublesex alternative splicing by transformer and transformer-2 in Drosphila. Science 252:833-836.
29. 28a.Huang, M., and J. B. Cohen. Unpublished data.
30. Hwang, D. Y., and J. B. Cohen. 1996. Base pairing at the 5′ splice site with U1 small nuclear RNA promotes splicing of the upstream intron but may be dispensable for splicing of the downstream intron. Mol. Cell. Biol. 16:3012-3022.
31. Ihle, J. N., B. Smith-White, B. Sisson, et al. 1989. Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-ceIl leukemia. J. Virol. 63:2959-2966.
32. Ishii, S., G. T. Merlino, and I. Pastan. 1985. Promoter region of the human Harvey ras proto-oncogene:similarity to the EGF receptor proto-oncogene promoter. Science 230:1378-1381.
33. Kuo, H. C., F. H. Nasim, and P. J. Grabowski. 1991. Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. Science 251:1045-1050.
34. Lavigueur, A., H. La Branche, A. K. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate EDI exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405-2417.
35. Lee, W., and E. B. Keller. 1991. Regulatory elements mediating transcription of the human Ha-ras gene. J. Mol. Biol. 220:599-011.
36. Lin, C. H., and J. G. Patton. 1995. Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1:234-245.
37. Lou, H., R. F. Gagel, and S. M. Berget. 1996. An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev. 10:208-219.
38. Lowy, D. R., and B. M. Willumsen. 1993. Function and regulation of ras. Annu. Rev. Biochem. 62:851-891.
39. Lührmann, R. 1988. snRNP proteins, p. 71-99. In M. L. Birnstiel (ed.). Structure and function of major and minor small nuclear ribonucleoprotein particles. Springer-Verlag, New York, N.Y.
40. Lutz, C. S., and J. C. Alwine. 1994. Direct interaction of the U1 snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal. Genes Dev. 8:576-586.
41. Lutz, C. S., K. U. Murthy, N. Schek, J. P. O'Cunnor, J. L. Manley, and J. C. Alwine. 1996. Interaction between the U1 snRNP-A protein and the 160-kD subunit of eleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. Genes Dev. 10:325-337.
42. Lutz-Freyermuth, C., C. C. Query, and J. D. Keene. 1990. Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc. Natl. Acad. Sci. USA 87:6393-6397.
43. Lynch, K. W., and T. Maniatis. 1995. Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev. 9:284-293.
44. Makris, A., C. Patriotis, S. E. Bear, and P. N. Tsichlis. 1993. Structure of a Moloney murine leukemia virus-virus-like 30 recombinant:implications for transduction of the e-H-ras proto-oncogene. J. Virol. 67:1286-1291.
45. Manley, J. L. 1995. A complex protein assembly catalyzes polyadenylntion of mRNA precursors. Curr. Opin. Genet. Dev. 5:222-228.
46. Manley, J. L. and N. J. Proudfoot. 1994. RNA 3′ ends:formation and function-meeting review. Genes Dev. 8:259-264.
47. Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1509-1579.
48. Maquat, L. E. 1995. When cells stop making sense:effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1:453-465.
49. McGrath, J. P., D. J. Capon, D. V. Goeddel, and A. D. Levinson. 1984. Comparative biochemical properties of normal and activated human ras p21 protein. Nature 310:644-649.
50. Mullen, M. P., C. W. Smith, J. G. Patton, and B. Nadal-Ginard. 1991. Alpha-tropomyosin mutually exclusive exon selection:competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev. 5:642-655.
51. Nagoshi, R. N., and B. S. Baker. 1990. Regulation of sex-specific RNA splicing at the Drossphila doublesex gene:cis-acting mutations in exon sequences alter sex-specific RNA splicing patterns. Genes Dev. 4:89-97.
52. Nsic, D., J. Cheng, and L. E. Maquat. 1993. Sequences within the last intron function in RNA 3′-end formation in cultured cells. Mol. Cell. Biol. 13:3359-3369.
53. Paterson, H., B. Reeves, R. Brown, A. Hall, M. Furth, J. Bos, P. Jones, and C. Marshall. 1987. Activated N-ras controls the transformed phenotype of HT 1080 human fibrosarcoma cells. Cell 51:803-812.
54. Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and T. A. Cooper. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15:4898-4907.
55. Rasheed, S., G. L. Norman, and G. Heidecker. 1983. Nucleotide sequence of the Rasheed rat sarcoma virus oncogene:new mutations. Science 221:155-157.
56. Reddy, E. P. 1983. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220:1061-1063.
57. Reddy. E. P., D. Lipman, P. R. Andersen, S. R. Tronick, and S. A. Aaronson. 1985. Nucleotide sequence analysis of the BALB/C murine sarcoma virus transforming gene. J. Virol. 53:984-987.
58. Reed, R. 1996. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6:215-220.
59. Reed, R., and T. Maniatis. 1988. The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev. 2:1268-1276.
60. Rickketts. M. H., and A. D. Levinson. 1988. High-level expression of c-H-ras-1 fails to fully transform Rat-1 cells. Mol. Cell. Biol. 8:1400-1468.
61. Rubberson, B. L., G. J. Cote, and S. M. Berget. 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:84-94.
62. Roscigno, R. F., M. Weiner, and M. A. Garcia-Blanco. 1993. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:11222-11229.
63. Ruta, M., R. Wolford, R. Dhar, D. Defeo-Jones, R. W. Ellis, and E. M. Scolnick. 1986. Nucleotide sequence of the two rut cellular rasH genes. Mol. Cell. Biol. 6:1706-1710.
64. Ryner, L. C., and B. S. Baker. 1991. Regulation of doublesex pre-mRNA processing occurs by 3′-splice site activation. Genes Dev. 5:2071-2085.
65. Scherly, D., W. Boelens, W. J. van Venrooij, N. A. Dathan, J. Hamm, and I. W. Mattaj. 1989. Identification of the RNA binding segment of humun U1 A protein and definition of its binding site on U1 snRNA. EMBO J. 8:4103-4170.
66. Seeburg, P. H., W. W. Colby, D. J. Capon, D. V. Goeddel, and A. D. Levinson. 1984. Biological properties of human c-Ha-ras-1 genes mutated at cudon 12. Nature 312:71-75.
67. Sheets, M. D., S. C. Ogg, and M. P. Wickens. 1990. Point mutations in AAU AAA and the poly (A) addition site:effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 18:5799-5805.
68. Singh, R., J. Valcarcel, and M. R. Green. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173-1176.
69. Soeda, E., and S. Yasuda. 1985. Harvey murine sarcoma virus (Ha-MSV) genome, p. 928-939. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses, 2nd ed. Cold Spring Harbor Laboratory Press, Cold J Spring Harbor, N.Y.
70. Staffa, A., and A. Cochrane. 1995. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597-4605.
71. Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and arc present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670-7682.
72. Strijker, R., D. T. Fritz, and A. D. Levinson. 1989. Adenovirus VAI-RNA regulates gene expression by controlling stability of ribosome-bound RNAs. EMBO J. 8:2669-2675.
73. Swain, A., and J. M. Coffin. 1992. Mechanism of transduction by retroviruses. Science 255:841-845.
74. Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14:1347-1354.
75. Tian, M., and T. Maniatis. 1992. Positive control of pre-mRNA splicing in vitro. Science 256:237-240.
76. van Oers, C. C., G. J. Adema, H. Zandberg, T. C. Moen. and P. D. Baas. 1994. Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA. Mol. Cell. Biol. 14:951-960.
77. Varmus, H. E. 1984. The molecular genetics of cellular oncogenes. Annu. Rev. Genet. 18:553-612.
78. Wang, Z., H. M. Hoffmann, and P. J. Grabowski. 1995. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1:21-35.
79. Wassarman, K. M., and J. A. Steitz. 1993. Association with terminal exons in pre-mRNAs:a new role for the U1 snRNP? Genes Dev. 7:647-659.
80. Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7:407-418.
81. Westaway, D., J. Papkoff, C. Moscovici, and H. E. Varmus. 1986 Identification of a provirally activated c-Ha-ras oncogene in an avian nephroblastoma via a novel procedure:cDNA cloning of a chimaeric viral-host transcript. EMBO J. 5:301-309.
82. Wilusz, J., S. M. Pettine, and T. Shenk. 1989. Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal. Nucleic Acids Res. 17:3899-3908.
83. Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660-3674.
84. Yenkley, J. M., J.-P. Morfin, M. G. Rosenfeld, and X.-D. Fu. 1996. A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer. Proc. Natl. Acad. Sci. USA 93:7582-7587.
85. Zamore, P. D., J. G. Patton, and M. R. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355:609-614.
86. Zhang, J., and H. M. Termin. 1993. Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science 259:234-238.
87. Zhuang, Y. A., A. M. Goldstein, and A. M. Weiner. 1989. UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc. Natl. Acad. Sci. USA 86:2752-2756.
88. Zuo, P., and T. Maniatis. 1996. The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 10:1356-1368.